BPM
GHDX

Bowling Portfolio Management’s Genomic Health, Inc. GHDX Stock Holding History

Bowling Portfolio Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,897
Closed -$401K – 401
2019
Q2 		$401K Sell
6,897
-676
-9% -$40K 0.07% 282
2019
Q1 		$530K Sell
7,573
-32
-0.4% -$2.37K 0.08% 286
2018
Q4 		$490K Sell
7,605
-5,803
-43% -$407K 0.09% 286
2018
Q3 		$942K Buy
+13,408
New +$784K 0.13% 246
2017
Q4 		– Sell
-19,947
Closed -$640K – 438
2017
Q3 		$640K Buy
+19,947
New +$629K 0.1% 271

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Bowling Portfolio Management's GHDX Position: Q3 2019 in Review

Bowling Portfolio Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 6,897 shares — an estimated $401K sold.

Bowling Portfolio Management first reported a position in GHDX in Q3 2017 and held it in 5 quarters. The position peaked at $942K in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Bowling Portfolio Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Bowling Portfolio Management sold 6,897 Genomic Health, Inc. shares in Q3 2019, an estimated $401K.
  • Bowling Portfolio Management first reported a position in Genomic Health, Inc. in Q3 2017 and held it in 5 quarters.
  • Bowling Portfolio Management's Genomic Health, Inc. position peaked at $942K in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Bowling Portfolio Management's 13F filing for Q3 2019, filed 15 Oct 2019.